Parallel comparison of apheresis-collected platelet concentrates stored in four different additive solutions

Vox Sanguinis

Volumn 105, Issue 4, 2013, Pages 305-312

  Nogawa, M ^a   Naito, Y ^a,b   Chatani, M ^c   Onodera, H ^c   Shiba, M ^a   Okazaki, H ^a   Matsuzaki, K ^d   Satake, M ^a   Nakajima, K ^d   Tadokoro, K ^a  

^a SUWA RED CROSS HOSPITAL   (Japan)

^b Japanese Red Cross Hokkaido Block Blood Center   (Japan)

^c Japanese Red Cross Kanto Koshinetsu Block Blood Center   (Japan)

^d Tokyo Metropolitan West Red Cross Blood Center   (Japan)

Author keywords

C3a; CD62P; Glucose consumption; Platelet additive solution; RANTES; SCD40L

Indexed keywords

CHEMOKINE; COMPLEMENT COMPONENT C3A; COMPOSOL; DRUG ADDITIVE; FIBRINOPEPTIDE A; INTERSOL; M SOL; PLASMA PROTEIN; RANTES; SSP; THROMBOCYTE CONCENTRATE; UNCLASSIFIED DRUG;

APHERESIS; ARTICLE; BLOOD AUTOTRANSFUSION; BLOOD DONOR; COMPARATIVE STUDY; CONTROLLED STUDY; GLUCOSE INTAKE; HUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; THROMBOCYTE ACTIVATION; THROMBOCYTE PRESERVATION;

C3A; CD62P; GLUCOSE CONSUMPTION; PLATELET ADDITIVE SOLUTION; RANTES; SCD40L;

BLOOD PLATELETS; BLOOD PRESERVATION; GLUCOSE; HUMANS; PLATELET ACTIVATION; PLATELETPHERESIS; SOLUTIONS;

EID: 84885484770     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/vox.12064     Document Type: Article

References (31)

1. Gulliksson H: Storage of platelets in additive solutions: the effect of citrate and acetate in in vitro studies. Transfusion 1993; 33:301-303
2. Gulliksson H, Larsson S, Kumlien G, et al.: Storage of platelets in additive solutions: effects of phosphate. Vox Sang 2000; 78:176-184
3. Gulliksson H, AuBuchon JP, Cardigan R, et al.: Storage of platelets in additive solutions: a multicentre study of the in vitro effects of potassium and magnesium. Vox Sang 2003; 85:199-205
4. de Wildt-Eggen J, Schrijver JG, Bins M, et al.: Storage of platelets in additive solutions: effects of magnesium and/or potassium. Transfusion 2002; 42:76-80
5. Sheu JR, Hsiao G, Shen MY, et al.: Mechanisms involved in the antiplatelet activity of magnesium in human platelets. Br J Haematol 2002; 119:1033-1041
6. van der Meer PF, Pietersz RN, Reesink HW: Storage of platelets in additive solution for up to 12 days with maintenance of good in-vitro quality. Transfusion 2004; 44:1204-1211
7. Hirayama J, Azuma H, Fujihara M, et al.: Storage of platelets in a novel additive solution (M-sol), which is prepared by mixing solutions approved for clinical use that are not especially for platelet storage. Transfusion 2007; 47:960-965
8. Holme S, Heaton WA, Courtright M: Improved in vivo and in vitro viability of platelet concentrates stored for seven days in a platelet additive solution. Br J Haematol 1987; 66:233-238
9. Wagner SJ, Skripchenko A, Myrup A, et al.: Calcium is a key constituent for maintaining the in vitro properties of platelets suspended in the bicarbonate-containing additive solution M-sol with low plasma levels. Transfusion 2010; 50:1028-1035
10. Azuma H, Hirayama J, Akino M, et al.: Platelet additive solution - electrolytes. Transfus Apheres Sci 2011; 44:277-281
11. Gyongyossy-Issa MI, Zhang JG, Culibrk B, et al.: Novel system for storage of buffy-coat-derived platelet concentrates in a glucose-based platelet additive solution: parameters and metabolism during storage and comparison to plasma. Vox Sang 2009; 97:102-109
12. VandenBroeke T, Dumont LJ, Hunter S, et al.: Platelet storage solution effects on the accuracy of laboratory tests for platelet function: a multi-laboratory study. Vox Sang 2004; 86:183-188
13. Radwanski K, Min K: The role of bicarbonate in platelet additive solution for apheresis platelet concentrates stored with low residual plasma. Transfusion 2013; 53:591-599
14. Azuma H, Hirayama J, Akino M, et al.: Reduction in adverse reactions to platelets by the removal of plasma supernatant and resuspension in a new additive solution (M-sol). Transfusion 2009; 49:214-218
15. Dekkers DW, De Cuyper IM, van der Meer PF, et al.: Influence of pH on stored human platelets. Transfusion 2007; 47:1889-1895
16. Sandgren P, Mayaudon V, Payrat JM, et al.: Storage of buffy-coat-derived platelets in additive solutions: in vitro effects on platelets stored in reformulated PAS supplied by a 20% plasma carry-over. Vox Sang 2010; 98:415-422
17. Simak J, Gelderman MP: Cell membrane microparticles in blood and blood products: potentially pathogenic agents and diagnostic markers. Transfus Med Rev 2006; 20:1-26
18. Devine DV, Bradley AJ, Maurer E, et al.: Effects of prestorage white cell reduction on platelet aggregate formation and the activation state of platelets and plasma enzyme systems. Transfusion 1999; 39:724-734
19. Rank A, Nieuwland R, Liebhardt S, et al.: Apheresis platelet concentrates contain platelet-derived and endothelial cell-derived microparticles. Vox Sang 2011; 100:179-186
20. Verma SP, Wallach DF: Erythrocyte membranes undergo cooperative, pH-sensitive state transitions in the physiological temperature range: evidence from Raman spectroscopy. Proc Natl Acad Sci USA 1976; 73:3558-3561
21. Boilard E, Nigrovic PA, Larabee K, et al.: Platelets amplify inflammation in arthritis via collagen-dependent microparticle production. Science 2010; 327:580-583
22. Savage WJ, Savage JH, Tobian AA, et al.: Allergic agonists in apheresis platelet products are associated with allergic transfusion reactions. Transfusion 2012; 52:575-581
23. Heddle NM, Klama L, Singer J, et al.: The role of the plasma from platelet concentrates in transfusion reactions. N Engl J Med 1994; 331:625-628
24. Muylle L, Joos M, Wouters E, et al.: Increased tumor necrosis factor alpha (TNF alpha), interleukin 1, and interleukin 6 (IL-6) levels in the plasma of stored platelet concentrates: relationship between TNF alpha and IL-6 levels and febrile transfusion reactions. Transfusion 1993; 33:195-199
25. Aye MT, Palmer DS, Giulivi A, et al.: Effect of filtration of platelet concentrates on the accumulation of cytokines and platelet release factors during storage. Transfusion 1995; 35:117-124
26. Stack G, Snyder EL: Cytokine generation in stored platelet concentrates. Transfusion 1994; 34:20-25
27. Bubel S, Wilhelm D, Entelmann M, et al.: Chemokines in stored platelet concentrates. Transfusion 1996; 36:445-449
28. Fujihara M, Ikebuchi K, Wakamoto S, et al.: Effects of filtration and gamma radiation on the accumulation of RANTES and transforming growth factor-beta1 in apheresis platelet concentrates during storage. Transfusion 1999; 39:498-505
29. Klüter H, Bubel S, Kirchner H, et al.: Febrile and allergic transfusion reactions after the transfusion of white cell-poor platelet preparations. Transfusion 1999; 39:1179-1184
30. Blumberg N, Gettings KF, Turner C, et al.: An association of soluble CD40 ligand (CD154) with adverse reactions to platelet transfusions. Transfusion 2006; 46:1813-1821
31. Bode AP, Miller DT: Generation and degradation of fibrinopeptide A in stored platelet concentrate. Vox Sang 1986; 51:192-196